< Back to search
Filter
1
Active & Responsive

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

for
Stargardt Disease, Stargardt Disease 1, Cone Rod Dystrophy,
Location: Boston MA, Baltimore MD, Gainesville FL, Ann Arbor MI,
Sponsor: Ascidian Therapeutics, Inc

Sex: All

Age: 5+

Code: NCT06445322

Recruiting
Active & Responsive

Study of ALK-001 on the Progression of Stargardt Disease

for
Stargardt Disease
Location: Fairfax VA, Erie PA, Gainesville FL, Columbus OH,
Sponsor: Alkeus Pharmaceuticals, Inc.

Sex: All

Age: 8 - 45

Code: NCT07419334

Phase3, Recruiting
New

A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions

for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Cincinnati OH, Dallas TX, Phoenix AZ
Sponsor: Astellas Institute for Regenerative Medicine

Sex: All

Age: 6+

Code: NCT07734064

Phase1, Recruiting

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

for
Stargardt, Stargardt's Disease, Stargardt Disease, STGD1
Location: Boston MA, New York NY, Baltimore MD, Durham NC,
Sponsor: Splice Bio

Sex: All

Age: 12 - 65

Code: NCT06435000

Recruiting

Stem Cell Ophthalmology Treatment Study II

for
Retinal Disease, Age-Related Macular Degeneration,
Location: Westport CT, Coral Springs FL
Sponsor: MD Stem Cells

Sex: All

Age: 18+

Code: NCT03011541

Recruiting

Interested in new stargardt disease trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

for
Stargardt Disease, Stargardt Macular Degeneration,
Location: Boston MA, Miami FL, Dallas TX, Aurora CO, Portland OR
Sponsor: Splice Bio

Sex: All

Age: 12 - 65

Code: NCT06942572

Phase1, Phase2, Recruiting

Rod and Cone Mediated Function in Retinal Disease

for
Retinal Degeneration, Retinitis Pigmentosa, Stargardt's Disease
Location: Bethesda MD
Sponsor: National Eye Institute (NEI)

Sex: All

Age: 5 - 70+

Code: NCT02617966

Recruiting

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

for
Stargardt Disease, Cone Rod Dystrophy,
Location: Boston MA, Baltimore MD, Miami FL, Gainesville FL,
Sponsor: Ascidian Therapeutics, Inc

Sex: All

Age: 12+

Code: NCT06467344

Phase1, Phase2, Recruiting

A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT

for
Macular Degeneration, Geographic Atrophy, Stargardt Disease
Location: Dallas TX
Sponsor: Nanoscope Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06805474

Recruiting

Phase 1 Study of C.001 in Retinal Degeneration

for
Geographic Atrophy, Stargardt Disease, RPE-mediated Maculopathy,
Location: Beverly Hills CA
Sponsor: Cellio Therapeutics Inc

Sex: All

Age: 18+

Code: NCT07594236

Phase1, Recruiting

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

for
Stargardt Disease
Location: Pittsburgh PA, Bellaire TX, Bakersfield CA
Sponsor: Ray Therapeutics, Inc.

Sex: All

Age: 16+

Code: NCT07439887

Phase1, Phase2, Recruiting

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Philadelphia PA, Durham NC, Miami FL, Pittsburgh PA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 6+

Code: NCT07425574

Recruiting

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

for
Stargardt Disease
Location: Jacksonville FL, Rochester MN, Bellaire TX, Dallas TX,
Sponsor: AAVantgarde Bio Srl

Sex: All

Age: 8 - 55

Code: NCT07161544

Phase1, Phase2, Recruiting

The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

for
Alcohol Use Disorder, Retinal Dystrophies,
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT06319872

Phase1, Recruiting

Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration

for
Retinitis Pigmentosa, Choroideremia,
Location: Irvine CA
Sponsor: Ray Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06375239

Recruiting

Inherited Retinal Degenerative Disease Registry

for
Eye Diseases Hereditary, Retinal Disease, Achromatopsia,
Location: Columbia MD
Sponsor: Foundation Fighting Blindness

Sex: All

Age: 0+

Code: NCT02435940

Recruiting

Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)

for
Retinitis Pigmentosa, Stargardt Macular Dystrophy,
Location: Irvine CA
Sponsor: Ray Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07502664

Recruiting